,pfgcs1

Leila Nourani1, Anita Lotfi1,2, Hediye Vand-Rajabpour1

  • 1Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, P.O. Box: 1316943551, Tehran, Iran.

Molecular biotechnology
|January 24, 2024
PubMed
概括

使用Plasmodium falciparum生成细胞特异性1 (PfGCS1) 自组装纳米粒子 (SAPNs) 开发了一种新型疟疾传播阻断疫苗 (TBV),在小鼠中显示出免疫性. 优化纳米粒子配方是加强强大的抗疟疾免疫反应的关键.

相关概念视频